<DOC>
	<DOCNO>NCT00902785</DOCNO>
	<brief_summary>Identify early marker choroidal neovascularization ( CNV ) fellow eye patient CNV eye due age-related macular degeneration expectation able identify patient need intervention .</brief_summary>
	<brief_title>A Study Of Early Markers Of Choroidal Neovascularization</brief_title>
	<detailed_description>CNV one eye dry AMD</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Sub , extra juxtafoveal choroidal neovascularization ( CNV ) macular scar due AMD nonstudy eye . No CNV geographic atrophy study eye . Best correct visual acuity study eye great 20/40 good 70 ETDRS letter . Sufficiently clear ocular medium adequate pupillary dilatation permit good quality fundus image study eye . Subjects either sex , age 50 year . Evidence sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect trial . Willing able comply schedule visit , laboratory test , trial procedure . Subjects present follow include study : Evidence manifest CNV FA , color photography ICG angiography study eye . Any prior treatment CNV study eye ( exclude vitamin AREDS formula ) . Significant medium opacity , include cataract , might interfere visual acuity assessment , fundus imaging study eye . Subjects enter likelihood require cataract surgery within follow 2 year . Presence cause choroidal neovascularization fellow eye , include pathologic myopia ( spherical equivalent 8 diopter negative , axial length 25 mm ) , ocular histoplasmosis syndrome , angioid streak , choroidal rupture , multifocal choroiditis . Any progressive eye disease AMD ( eg , glaucoma , diabetic retinopathy ) study eye . Presence subretinal hemorrhage , serous hemorrhagic pigment epithelial detachment , subretinal fibrosis pigment epithelial tear rip study eye . Any medical condition would interfere patient 's ability complete trial . Concurrent enrollment observational interventional clinical study . Any treatment ocular systemic investigational agent past 60 day medical condition . Known serious allergy dye use fluorescein angiography ICG .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>exploratory</keyword>
	<keyword>observational</keyword>
	<keyword>non-interventional study age-related macular degeneration ( AMD ) choroidal neovascularization ( CNV )</keyword>
</DOC>